Personality dimensions and psychopathological profiles of Ecstasy users

被引:49
|
作者
Dughiero, G
Schifano, F
Forza, G
机构
[1] Addict Treatment Unit 1, Local Hlth Unit 16, Padua, Italy
[2] Univ London St Georges Hosp, Sch Med, Dept Addict Behav & Psychol Med, London SW17 0RE, England
关键词
MDMA; Ecstasy; SCL-90; TPQ; drug prevention;
D O I
10.1002/hup.346
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Only limited information is available with respect to personality traits and the psychopathological characteristics of Ecstasy users. To shed some light on the issue, we compared a group of 43 Ecstasy consumers (made up of both 'experimenters', those who took less than or equal to 27.5 tablets in their lifetime, and 'abusers', those who took larger amounts of the drug) with a composite control group of 77 subjects (made up of drug-free people, cannabis users and users of illicit drugs other than Ecstasy). Three instruments were used: the Questionnaire for the Assessment of the Use of Entactogenic Drugs (to assess modalities and characteristics of Ecstasy use); the Cloninger Tridimensional Personality Questionnaire (which measures harm avoidance, reward dependence and novelty seeking) and the SCL-90 (which measures 10 different psychiatric variables). The Ecstasy consumer group subjects showed higher novelty seeking scores than the controls (p < 0.001), and Ecstasy experimenters showed lower harm avoidance scores than the abusers (p = 0.029), but values of both reward dependence and harm avoidance dimensions were associated with sex. On the SCL-90, Ecstasy users showed higher scores than the controls on the obsession-compulsion (p = 0.004), phobic anxiety (p = 0.037), psychoticism (p = 0.005) and sleep disturbances (p = 0.046) subscales. However, many of the SCL-90 subscale results were associated with sex, and only the psychoticism values seemed to suggest a clinical condition. The main finding of this study is that high novelty seeking scores are characteristic of Ecstasy consumers: The propensity to look selectively for novelties could possibly act as a predisposing factor for Ecstasy abuse itself. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:635 / 639
页数:5
相关论文
共 50 条
  • [31] Serotonin transporters in ecstasy users - Reply
    Ebmeier, KP
    Semple, DM
    Glabus, MF
    O'Carroll, RE
    Johnstone, EC
    BRITISH JOURNAL OF PSYCHIATRY, 2000, 176 : 194 - 195
  • [32] Neuropsychological performance of MDMA (ecstasy) users
    Lyvers, M
    Barker, B
    AUSTRALIAN JOURNAL OF PSYCHOLOGY, 2002, 54 : 42 - 42
  • [33] Ecstasy users face consequences of neurotoxicity
    Morris, K
    LANCET, 1998, 352 (9144): : 1913 - 1913
  • [34] Attention, memory and monitoring in ecstasy users
    Bedi, G
    Redman, J
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A37 - A37
  • [35] Cognitive impairment and psychopathological dimensions in dementia
    Benoit, M
    Robert, P
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S63 - S63
  • [36] Plasma amino acids in ecstasy users
    Stuerenburg, HJ
    Petersen, K
    Buhmann, C
    Rosenkranz, M
    Baeumer, T
    Thomasius, R
    NEUROENDOCRINOLOGY LETTERS, 2003, 24 (05) : 348 - 349
  • [37] Why do Ecstasy users quit?
    Morgan, MJ
    BEHAVIOURAL PHARMACOLOGY, 2002, 13 (5-6): : 495 - 495
  • [38] Patterns of ecstasy use by drug users
    Hammersley, R
    Ditton, J
    Smith, I
    Short, E
    BRITISH JOURNAL OF CRIMINOLOGY, 1999, 39 (04): : 625 - 647
  • [39] Brain electric activity in ecstasy users
    Gamma, A
    Brandeis, D
    Lehmann, D
    Pascual-Marqui, RD
    Brandeis, R
    Vollenweider, FX
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2004, 54 (1-2) : 31 - 31
  • [40] Psychopathological and Behavioural Dimensions in HIV Infection
    Margalho, R.
    Velez, J.
    Guzman, D.
    Oliveira, J.
    da Cunha, Saraiva
    Melico Silvestre, A. A.
    PSILOGOS, 2008, 5 (1-2) : 7 - 14